Notably, bindarit improved cardiac function, reduced fibrosis and increased capillary density after MI, effects associated with reduced ER stress markers (ATF4, CHOP and p-eIF2α) and DNA damage (γH2AX). This evidence concerns the gene EIF2A and myocardial infarction.